
Elgene Lim, MBBS, FRACP, PhD
Articles by Elgene Lim, MBBS, FRACP, PhD



In this overview, we will review recent developments in the management of breast cancer brain metastases and current prospective trials of systemic therapies specifically for patients with breast cancer brain metastases, with a focus on novel pathway-specific therapies.

In this article, we describe the long natural history of HR+ breast cancer and review current research and clinical strategies to address this clinical challenge.

The diagnosis of central nervous system (CNS) recurrence is a much dreaded outcome among breast cancer patients, and its incidence varies with disease stage and cancer subtype.
Latest Updated Articles
- 8 TiP Randomized, Multicenter, Phase 3 Study to Evaluate the Combination of Enobosarm and Abemaciclib Compared With Estrogen-Blocking Agent for the Second-Line Treatment of AR+, ER+, HER2– Metastatic Breast Cancer in Patients Who Have Previously Received Palbociclib and an Estrogen-Blocking Agent Combination Therapy
Published: April 18th 2022 | Updated:
- The Natural History of Hormone Receptor–Positive Breast Cancer
Published: August 10th 2012 | Updated:
- Updates on the Management of Breast Cancer Brain Metastases
Published: July 15th 2014 | Updated:
- New Insights and Emerging Therapies for Breast Cancer Brain Metastases
Published: July 15th 2012 | Updated: